We are thrilled to have welcomed our partners from the Morinaga Research Centre, Japan, to Bangladesh. This visit signifies a pivotal moment in our ongoing collaboration aimed at advancing development. The delegation engaged in insightful discussions on shared goals, explored opportunities for growth, and reviewed future strategies to enhance mutual success.
This partnership marks another milestone in our commitment to fostering global ties and bringing innovative solutions to the healthcare and pharmaceutical industries in Bangladesh.
More Releases
ZAS Corporation Celebrates 19th Anniversary with Team Participation
ZAS Corporation proudly marked its 19th anniversary, celebrating nearly two decades of excellence, innovation,...
|
16 Oct, 2024
Morinaga Research Centre Japan Visits Bangladesh to Strengthening Global Collaborations
We are thrilled to have welcomed our partners from the Morinaga Research Centre, Japan, to Bangladesh....
|
16 Oct, 2024
ZAS Corporation Secures Trademark for DECA Brand
We are proud to announce that ZAS Corporation Ltd. has officially secured the trademark for our brand...
|
05 Oct, 2024
ZAS Corporation Obtains Trademark for Protimeal Brand
We are delighted to announce that ZAS Corporation has successfully obtained the trademark for our brand...
|
05 Oct, 2024
ZAS Corporation Successfully Launches Celltrion Biosimilars in Bangladesh
We are proud to announce the successful launch of Celltrion’s biosimilar products in Bangladesh,...
|
31 Aug, 2024
ZAS Corporation Ltd. Unveils Vision for the Next Decade in Oncology at Sales Conference
Dhaka, Bangladesh – ZAS Corporation Ltd., a leading pharmaceutical company with a strong focus on oncology,...
|
07 Aug, 2024
ZAS Corporation and BSCCM Host Seminar on Hypophosphatemia and Re-Feeding Syndrome.
ZAS Corporation, in collaboration with the Bangladesh Society of Critical Care Medicine (BSCCM), recently...
|
06 Jun, 2024
ZAS Corporation Ltd. Commits to Advancing Neonatal Care at the 4th International Scientific Conference of Bangladesh Perinatal Society
ZAS Corporation Ltd. has pledged its support to the 4th International Scientific Conference of Bangladesh...
|
14 May, 2024
Bangladesh Endocrine Society and ZAS Corporation Collaborate to Advance Gonadal Hormone Replacement Therapy Knowledge.
In a groundbreaking collaboration, the Bangladesh Endocrine Society (BES) joined forces with medical...
|
09 May, 2024
ZAS Corporation Ltd. and Bangladesh Lung Foundation Host Scientific Seminar on RTI Prevention
In a promising stride towards combating respiratory infections, ZAS Corporation Ltd. joined hands with...
|
06 May, 2024